Globe Life Inc.GL
NYSE•Financial Services•Insurance - Life
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
Globe Life Inc. (GL) reported trailing twelve months revenue of $6.07B as of March 2026, a 4.0% increase year-over-year. Quarterly revenue reached $1.56B, reflecting continued top-line momentum.
Globe Life Inc. generated $1.18B in TTM net income, with quarterly EBITDA of $334.22M. The operating margin expanded from 21.3% to 21.4%, suggesting improving cost efficiency and pricing discipline.
The spread between operating margin (21.4%) and net margin (17.3%) indicates tight cost control with minimal non-operating drag. Net margin has improved from 17.2% a year ago, signaling stronger bottom-line efficiency.
GL trades at a P/E of 9.1x (below the broader market average) and a P/S of 1.8x. The price-to-book ratio of 1.8x reflects a moderate premium to book value.
The company generated $396.03M in free cash flow over the trailing twelve months, a 5.7% decrease year-over-year, indicating cash generation ability. The balance sheet shows $30.97B in total assets with $2.32B in long-term debt against $6.08B in stockholders equity for a debt-to-equity ratio of 0.4, a conservative capital structure. Data based on the most recent quarterly reports.
Competitive analysis based on 21 quarters of fundamental data
Operating margins are expanding at ~23.2%, suggesting durable pricing power and cost discipline.
Consistently high ROE averaging 20.3% suggests a durable competitive advantage and efficient capital allocation.
8 of the last 8 quarters generated positive FCF. The company generally funds itself but has occasional cash consumption quarters.
TTM revenue has grown consistently (7 of 7 quarters up), with ~7.4% growth over the period. Strong demand durability.
Data-driven red flags and warnings across 21 quarters
Margins are stable or improving at ~24.0% — no sign of cost or pricing stress.
FCF covers net income by 1.2x on average — earnings are well-supported by cash generation.
D/E ratio is 0.4 — conservative capital structure with low financial risk.
Revenue is stable or growing over recent quarters — demand appears durable.
Free cash flow is consistently positive — the business self-funds without external capital reliance.
Shares decreased 14.2% — net buybacks are reducing shares outstanding and boosting per-share value.
Quarterly standardized metrics.
Stock price and market valuation
Revenue and earnings growth across quarters
Assets, cash, debt, and leverage
Price multiples and return ratios
Operating efficiency and return metrics
Free cash flow, earnings quality, and capital allocation